Administered By

• Medicine, Hematologic Malignancies and Cellular Therapy

Awarded By

• National Institutes of Health 

Contributors

• Kang, Yubin Principal Investigator
• Li, Zhiguo Co Investigator
• Wang, Endi Co Investigator

Start/End

• January 1, 2019 - December 31, 2021